{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:37:27Z","timestamp":1784194647528,"version":"3.55.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"name":"Joint Program Executive Office"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Infection with the gram-negative bacterium Burkholderia pseudomallei can result in melioidosis, a life-threatening disease that can be difficult to diagnose. Culture remains the gold standard for diagnosis but requires laboratory resources not available in many endemic regions. A lateral flow immunoassay has shown promise for POC diagnostics but suffers from low sensitivity when used on blood samples. PCR also has low sensitivity on blood, attributed to the low bacterial numbers in blood observed in melioidosis patients, even when bacteraemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prototype i-STAT cartridge was developed to utilize the monoclonal antibody specific for the capsule of pathogenic Burkholderia species employed on the LFI. The resulting POC assay was evaluated on 414 clinical specimens from Darwin, Australia and Cambodia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The i-STAT assay accurately distinguished Australian blood culture positive melioidosis patients from Australian patients hospitalized with other infections (AUC = 0.91, 95% CI 0.817 - 1.0). We derived an assay cutoff with 76% sensitivity and 94% specificity that correctly classified 88% (n = 74) of the Australian patients. Interestingly, only 46% (6\/13) of the culture-positive melioidosis patients in Cambodia were classified correctly. Of great importance however, the assay detected capsule from blood samples for 32% of blood culture negative melioidosis patients in both cohorts and previously undiagnosed melioidosis patients in Cambodia. In addition the assay showed high sensitivity and specificity for urine, pus and sputum.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Diagnostic tools that are not dependent upon the growth kinetics or the levels of bacteremia of B. pseudomallei represent the next-generation of diagnostics and must be pursued further.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciy929","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T21:00:54Z","timestamp":1540846854000},"page":"421-427","source":"Crossref","is-referenced-by-count":14,"title":["Next-generation Diagnostics for Melioidosis: Evaluation of a Prototype i-STAT Cartridge to Detect Burkholderia pseudomallei Biomarkers"],"prefix":"10.1093","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5554-0133","authenticated-orcid":false,"given":"Kevin L","family":"Schully","sequence":"first","affiliation":[{"name":"Austere Environments Consortium for Enhanced Sepsis Outcomes, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Ft. Detrick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C","family":"Young","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mayo","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Darwin, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L","family":"Connolly","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rigas","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Darwin, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammarah","family":"Spall","sequence":"additional","affiliation":[{"name":"Austere Environments Consortium for Enhanced Sepsis Outcomes, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Ft. Detrick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa A","family":"Chan","sequence":"additional","affiliation":[{"name":"Austere Environments Consortium for Enhanced Sepsis Outcomes, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Ft. Detrick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G","family":"Salvador","sequence":"additional","affiliation":[{"name":"Austere Environments Consortium for Enhanced Sepsis Outcomes, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Ft. Detrick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V","family":"Lawler","sequence":"additional","affiliation":[{"name":"Austere Environments Consortium for Enhanced Sepsis Outcomes, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Ft. Detrick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A","family":"Opdyke","sequence":"additional","affiliation":[{"name":"Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, Medical Countermeasure Systems, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle V","family":"Clark","sequence":"additional","affiliation":[{"name":"Austere Environments Consortium for Enhanced Sepsis Outcomes, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Ft. Detrick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J","family":"Currie","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Darwin, Australia"},{"name":"Department of Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"2019071803462201300_CIT0001","first-page":"14","volume-title":"Melioidosis: The Great Mimicker, in Medicine Update. Volume 23","author":"Chandni","year":"2013"},{"key":"2019071803462201300_CIT0002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0034-1398389","article-title":"Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment","volume":"36","author":"Currie","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"2019071803462201300_CIT0003","first-page":"1","article-title":"Melioidosis cases and selected reports of occupational exposures to Burkholderia pseudomallei\u2013United States, 2008\u20132013","volume":"64","author":"Benoit","year":"2015","journal-title":"MMWR Surveill Summ"},{"key":"2019071803462201300_CIT0004","doi-asserted-by":"crossref","first-page":"e0194595","DOI":"10.1371\/journal.pone.0194595","article-title":"Performance evaluation of Active Melioidosis Detect-Lateral Flow Assay (AMD-LFA) for diagnosis of melioidosis in endemic settings with limited resources","volume":"13","author":"Shaw","year":"2018","journal-title":"PLoS One"},{"key":"2019071803462201300_CIT0005","doi-asserted-by":"crossref","first-page":"e2727","DOI":"10.1371\/journal.pntd.0002727","article-title":"Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis","volume":"8","author":"Houghton","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2019071803462201300_CIT0006","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02002-17","article-title":"Evaluation of a rapid diagnostic test for detection of Burkholderia pseudomallei in the Lao People\u2019s Democratic Republic","volume-title":"J Clin Microbiol","author":"Woods","year":"2018"},{"key":"2019071803462201300_CIT0007","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10096-018-3237-3","article-title":"Diagnostic accuracy of the InBiOS AMD rapid diagnostic test for the detection of Burkholderia pseudomallei antigen in grown blood culture broth","volume":"37","author":"Peeters","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019071803462201300_CIT0008","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1021\/acschembio.5b00502","article-title":"Burkholderia pseudomallei capsular polysaccharide recognition by a monoclonal antibody reveals key details toward a biodefense vaccine and diagnostics against melioidosis","volume":"10","author":"Marchetti","year":"2015","journal-title":"ACS Chem Biol"},{"key":"2019071803462201300_CIT0009","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/IAI.01313-09","article-title":"A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists","volume":"78","author":"Propst","year":"2010","journal-title":"Infect Immun"},{"key":"2019071803462201300_CIT0010","first-page":"108","article-title":"Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders","volume":"2","author":"Burtnick","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"2019071803462201300_CIT0011","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1371\/journal.pntd.0000900","article-title":"The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study","volume":"4","author":"Currie","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"2019071803462201300_CIT0012","doi-asserted-by":"crossref","first-page":"e0005923","DOI":"10.1371\/journal.pntd.0005923","article-title":"Melioidosis in lower provincial Cambodia: a case series from a prospective study of sepsis in Takeo Province","volume":"11","author":"Schully","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2019071803462201300_CIT0013"},{"key":"2019071803462201300_CIT0014","doi-asserted-by":"crossref","first-page":"15008","DOI":"10.1038\/nmicrobiol.2015.8","article-title":"Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis","volume":"1","author":"Limmathurotsakul","year":"2016","journal-title":"Nat Microbiol"},{"key":"2019071803462201300_CIT0015","doi-asserted-by":"crossref","first-page":"e12485","DOI":"10.1371\/journal.pone.0012485","article-title":"Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models","volume":"5","author":"Limmathurotsakul","year":"2010","journal-title":"PLoS One"},{"key":"2019071803462201300_CIT0016","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/AEM.20.5.825-833.1970","article-title":"Serological diagnosis of human melioidosis with indirect hemagglutination and complement fixation tests","volume":"20","author":"Alexander","year":"1970","journal-title":"Appl Microbiol"},{"key":"2019071803462201300_CIT0017","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/infdis\/160.2.253","article-title":"Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis","volume":"160","author":"Ashdown","year":"1989","journal-title":"J Infect Dis"},{"key":"2019071803462201300_CIT0018","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4269\/ajtmh.2011.11-0114a","article-title":"The use of positive serological tests as evidence of exposure to Burkholderia pseudomallei","volume":"84","author":"Peacock","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"2019071803462201300_CIT0019","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0035-9203(00)90333-X","article-title":"Melioidosis: acute and chronic disease, relapse and re-activation","volume":"94","author":"Currie","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2019071803462201300_CIT0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4269\/ajtmh.2006.74.330","article-title":"Indirect hemagglutination assay in patients with melioidosis in northern Australia","volume":"74","author":"Cheng","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"2019071803462201300_CIT0021","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1537-2995.2006.00965.x","article-title":"Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening","volume":"46","author":"Chang","year":"2006","journal-title":"Transfusion"},{"key":"2019071803462201300_CIT0022","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/CVI.00026-09","article-title":"Clinical features that affect indirect-hemagglutination-assay responses to Burkholderia pseudomallei","volume":"16","author":"Harris","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"2019071803462201300_CIT0023","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1128\/JCM.00291-07","article-title":"Development of real-time PCR assays and evaluation of their potential use for rapid detection of Burkholderia pseudomallei in clinical blood specimens","volume":"45","author":"Supaprom","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2019071803462201300_CIT0024","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1099\/jmm.0.000098","article-title":"Rapid diagnostics for melioidosis: a comparative study of a novel lateral flow antigen detection assay","volume":"64","author":"Robertson","year":"2015","journal-title":"J Med Microbiol"},{"key":"2019071803462201300_CIT0025","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4269\/ajtmh.2007.77.812","article-title":"Quantitation of B. pseudomallei in clinical samples","volume":"77","author":"Wuthiekanun","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"2019071803462201300_CIT0026"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/3\/421\/28949650\/ciy929.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T07:53:40Z","timestamp":1605340420000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/3\/421\/5149535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,10,31]]},"published-print":{"date-parts":[[2019,7,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy929","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8,1]]},"published":{"date-parts":[[2018,10,31]]}}}